Medicina Basada en la Evidencia

CONSORT. Guía para la elaboración de manuscritos de ensayos clínicos aleatorizados – 315 – BIBLIOGRAFÍA Boutron I, Altman DG, Moher D, Schulz KF, Ravaud P; CONSORT NPT Group. CONSORT Statement for Randomized Trials of Nonpharmacologic Treatments: A 2017 Update and a CONSORT Extension for Nonpharmacologic Trial Abstracts. Ann Intern Med. 2017;167:40-7. Butcher NJ, Monsour A, Mew EJ, Chan AW, Moher D, Mayo- Wilson E, et al . Guidelines for Reporting Outcomes in Trial Reports: The CONSORT-Outcomes 2022 Extension. JAMA. 2022;328:2252-64. Calvert M, Blazeby J, Altman D, Revicki D, Moher D, Brundage MD; CONSORT PRO Group. Reporting of Patient-Reported Outcomes in Randomized Trials: The CONSORT PRO Extension. JAMA. 2013;309:814-22. Cobos-Carbó A, Augustovski F. Declaración CONSORT 2010: actualización de la lista de comprobación para informar ensayos clínicos aleatorizados de grupos paralelos. Med Clin (Barc). 2011;137:213-5. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials | EQUATOR Network [en línea] [citado el 30/12/2023]. Disponible en www.equator- network.org/reporting-guidelines/consort/ Gagnier JJ, Boon H, Rochon P, Moher D, Barnes J, Bombardier C; CONSORT Group. Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT Statement. Ann Intern Med. 2006;144:364-7. González de Dios J, Buñuel Álvarez JC, González Rodríguez P. Listas guía de comprobación de ensayos clínicos: declaración CONSORT. Evid Pediatr. 2011;7:72. González de Dios J, M. González-Muñoz A, Alonso-Arroyo R, Aleixandre-Benavent. Comunicación científica (XIX). Conocimientos básicos para leer (y escribir) un artículo científico (6): Listas de comprobación de estudios experimentales. Acta Pediatr Esp. 2015;73:19-24. Hemming K, Taljaard M, Grimshaw J. Introducing the new CONSORT extension for stepped-wedge cluster randomised trials. Trials. 2019;20:68. Hopewell S, Boutron I, Chan A, Collins GS, de Beyer JA, Hróbjartsson A, et al . An update to SPIRIT and CONSORT reporting guidelines to enhance transparency in randomized trials. Nat Med. 2022;28:1740-3. Junqueira DR, Zorzela l, Golder S, Loke Y, Gagnier JJ, Julious SA, et al . CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomised trials. BMJ. 2023;381:e073725. Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, et al . CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869. Moraga J, Cartes-Velásquez R, Documentos: Pautas de Chequeo, Parte I: CONSORT Y TREND. Rev Chil Cir. 2015;67:225-32. Moreno-Ramírez D, Arias-Santiago S, Nagore E, Gilaberte Y. Editorial. CONSORT, STROBE y STARD. Instrumentos de ayuda para la publicación de resultados de la investigación. Actas Dermosifiliogr. 2015;106:79-81. Muchai Manyara A, Davies P, Stewart D, Weir C, Young A, Butcher N, et al . Protocol for the development of SPIRIT and CONSORT extensions for randomised controlled trials with surrogate primary endpoints: SPIRIT-SURROGATE and CONSORT-SURROGATE. BMJ Open. 2022:e064304. Orduña Malea E, Alonso Arroyo A, Ontalba Ruiperez J, Catalá López F. Evaluating the online impact of reporting guidelines for randomised trial reports and protocols: a crosssectional webbased data analysis of CONSORT and SPIRIT initiatives. Scientometrics 2023;128:407-40. Wiehn J, Nonte J, Prugger C. Reporting quality for abstracts of randomised trials on child and adolescent depression prevention: a meta-epidemiological study on adherence to CONSORT for abstracts. BMJ Open. 2022:e061873.